Mariia Ivanova, transl. “Guideline Summary NGC (2016): Canagliflozin, Dapagliflozin and Empagliflozin As Monotherapies for Treating Type 2 Diabetes”. KIDNEYS, no. 4.18 (September 9, 2021): 36. Accessed September 10, 2026. https://mail.kidneysjournal.com/index.php/journal/article/view/137.